Search Results - "Rindi, Guido"

Neuroendocrine neoplasm update: toward universal nomenclature by Rindi, Guido, Inzani, Frediano

“…Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine organs, the nerve structures or in the so-called diffuse…”
Get full text

Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine by Rindi, Guido, Wiedenmann, Bertram

“…Over the past 5 years, a number of notable research advances have been made in the field of neuroendocrine cancer, specifically with regard to neuroendocrine…”
Get full text

3. The ENETS Guidelines: The New TNM Classification System by Rindi, Guido

“…The WHO definition of the 3 classes of well differentiated endocrine tumor, well differentiated endocrine carcinoma and poorly differentiated carcinoma, allows…”
Get full text

The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia by Inzani, Frediano, MD, PhD, Petrone, Gianluigi, MD, PhD, Rindi, Guido, MD, PhD

“…Based on the 2010 version, the 2017 World Health Organization (WHO 2017) classification is for pancreatic neuroendocrine neoplasms (PanNEN). The WHO 2017…”
Get full text

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms by Rindi, Guido, Mete, Ozgur, Uccella, Silvia, Basturk, Olca, La Rosa, Stefano, Brosens, Lodewijk A. A., Ezzat, Shereen, de Herder, Wouter W., Klimstra, David S., Papotti, Mauro, Asa, Sylvia L.

“…In this review, we detail the changes and the relevant features that are applied to neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine…”
Get full text

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors by Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Blumberg, Joëlle, Ruszniewski, Philippe

“…As compared with placebo, extended-release lanreotide (120 mg every 28 days) was associated with delayed disease progression in patients with nonfunctional,…”
Get full text

Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms by Leoncini, Emanuele, Boffetta, Paolo, Shafir, Michail, Aleksovska, Katina, Boccia, Stefania, Rindi, Guido

“…Purpose The incidence of neuroendocrine neoplasms is increasing. This work aimed at: (i) establishing worldwide incidence trend of low-grade neuroendocrine…”
Get full text

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal by Rindi, Guido, Klimstra, David S., Abedi-Ardekani, Behnoush, Asa, Sylvia L., Bosman, Frederik T., Brambilla, Elisabeth, Busam, Klaus J., de Krijger, Ronald R., Dietel, Manfred, El-Naggar, Adel K., Fernandez-Cuesta, Lynnette, Klöppel, Günter, McCluggage, W. Glenn, Moch, Holger, Ohgaki, Hiroko, Rakha, Emad A., Reed, Nicholas S., Rous, Brian A., Sasano, Hironobu, Scarpa, Aldo, Scoazec, Jean-Yves, Travis, William D., Tallini, Giovanni, Trouillas, Jacqueline, van Krieken, J. Han, Cree, Ian A.

“…The classification of neuroendocrine neoplasms (NENs) differs between organ systems and currently causes considerable confusion. A uniform classification…”
Get full text

Reply to ‘Time for a change and to adopt a novel molecular genomic approach in NETs’ by Rindi, Guido, Wiedenmann, Bertram

Get full text

Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study by Iglesias-Garcia, Julio, MD, Poley, Jan-Werner, MD, Larghi, Alberto, MD, PhD, Giovannini, Marc, MD, PhD, Petrone, Maria Chiara, MD, Abdulkader, Ihab, MD, PhD, Monges, Genevieve, MD, PhD, Costamagna, Guido, MD, PhD, Arcidiacono, Paolo, MD, Biermann, Katharina, MD, PhD, Rindi, Guido, MD, PhD, Bories, Erwan, MD, Dogloni, Claudio, MD, PhD, Bruno, Marco, MD, PhD, Dominguez-Muñoz, J. Enrique, MD, PhD

“…Background EUS-guided FNA is an efficacious technique for sampling intraintestinal and extraintestinal mass lesions. However, cytology has limitations to its…”
Get full text

The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement by Klöppel, Günter, Rindi, Guido, Perren, Aurel, Komminoth, Paul, Klimstra, David S.

Get full text

Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study by Larghi, Alberto, MD, PhD, Capurso, Gabriele, MD, PhD, Carnuccio, Antonella, MD, PhD, Ricci, Riccardo, MD, PhD, Alfieri, Sergio, MD, Galasso, Domenico, MD, Lugli, Francesca, MD, Bianchi, Antonio, MD, Panzuto, Francesco, MD, PhD, De Marinis, Laura, MD, Falconi, Massimo, MD, Delle Fave, Gianfranco, MD, Doglietto, Giovanni Battista, MD, Costamagna, Guido, MD, FACG, Rindi, Guido, MD, PhD

“…Background Preoperative determination of Ki-67 expression, an important prognostic factor for grading nonfunctioning pancreatic endocrine tumors (NF-PETs),…”
Get full text

Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms by La Rosa, Stefano, MD, Inzani, Frediano, MD, Vanoli, Alessandro, MD, Klersy, Catherine, MD, Dainese, Linda, MD, Rindi, Guido, MD, PhD, Capella, Carlo, MD, Bordi, Cesare, MD, Solcia, Enrico, MD

“…Summary Gastric neuroendocrine neoplasms differ considerably in histology, clinicopathologic background, stage, and patient outcome, implying a wide spectrum…”
Get full text

Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome by Jann, Henning, Roll, Stephanie, Couvelard, Anne, Hentic, Olivia, Pavel, Marianne, Müller‐Nordhorn, Jacqueline, Koch, Martin, Röcken, Christoph, Rindi, Guido, Ruszniewski, Philippe, Wiedenmann, Bertram, Pape, Ulrich‐Frank

“…BACKGROUND: Prognostic classification of neuroendocrine tumor (NET) patients is difficult due to the complexity of current classification systems. A recent…”
Get full text

Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis by Milione, Massimo, Maisonneuve, Patrick, Pellegrinelli, Alessio, Grillo, Federica, Albarello, Luca, Spaggiari, Paola, Vanoli, Alessandro, Tagliabue, Giovanna, Pisa, Eleonora, Messerini, Luca, Centonze, Giovanni, Inzani, Frediano, Scarpa, Aldo, Papotti, Mauro, Volante, Marco, Sessa, Fausto, Fazio, Nicola, Pruneri, Giancarlo, Rindi, Guido, Solcia, Enrico, La Rosa, Stefano, Capella, Carlo

“…Mixed adenoneuroendocrine carcinomas (MANECs) are composed of a poorly differentiated neuroendocrine carcinoma (NEC) and a non-neuroendocrine (non-NEC)…”
Get full text

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors by Pape, Ulrich‐Frank, Jann, Henning, Müller‐Nordhorn, Jacqueline, Bockelbrink, Angelina, Berndt, Uta, Willich, Stefan N., Koch, Martin, Röcken, Christoph, Rindi, Guido, Wiedenmann, Bertram

“…BACKGROUND. Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a rare but challenging group of malignant neoplasms and occur at…”
Get full text

Postmodernism and the decline of the clinical autopsy by Dell’Aquila, Marco, Vetrugno, Giuseppe, Grassi, Simone, Stigliano, Egidio, Oliva, Antonio, Rindi, Guido, Arena, Vincenzo

Get full text

Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases by Vanoli, Alessandro, La Rosa, Stefano, Klersy, Catherine, Grillo, Federica, Albarello, Luca, Inzani, Frediano, Maragliano, Roberta, Manca, Rachele, Luinetti, Ombretta, Milione, Massimo, Doglioni, Claudio, Rindi, Guido, Capella, Carlo, Solcia, Enrico

“…Several types of neuroendocrine neoplasms (NENs) have been described in the duodenal tract, from low-grade tumors (NETs) to high-grade neuroendocrine…”
Get more information

Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study by Rufini, Vittoria, Lorusso, Margherita, Inzani, Frediano, Pasciuto, Tina, Triumbari, Elizabeth Katherine Anna, Grillo, Lucia Rosalba, Locco, Filippo, Margaritora, Stefano, Pescarmona, Edoardo, Rindi, Guido

“…Purpose To correlate somatostatin receptor (SSTR) and proliferative activity profile (SSTR2, SSTR5, Ki-67) at immunohistochemistry (IHC) with SSTR-PET/CT…”
Get full text

Gastroenteropancreatic neuroendocrine tumours by Modlin, Irvin M, Prof, Oberg, Kjell, Prof, Chung, Daniel C, MD, Jensen, Robert T, MD, de Herder, Wouter W, MD, Thakker, Rajesh V, Prof, Caplin, Martyn, MD, Delle Fave, Gianfranco, Prof, Kaltsas, Greg A, MD, Krenning, Eric P, Prof, Moss, Steven F, MD, Nilsson, Ola, Prof, Rindi, Guido, MD, Salazar, Ramon, MD, Ruszniewski, Philippe, Prof, Sundin, Anders, MD

“…Summary Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present many clinical challenges. They secrete peptides and…”
Get full text